Neville Rodie & Shaw’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-93,069
Closed -$9.24M 250
2019
Q3
$9.24M Sell
93,069
-670
-0.7% -$63.7K 0.98% 31
2019
Q2
$8.66M Sell
93,739
-7,865
-8% -$747K 0.92% 32
2019
Q1
$9.59M Sell
101,604
-3,707
-4% -$324K 1.02% 29
2018
Q4
$6.75M Sell
105,311
-12,319
-10% -$909K 0.82% 39
2018
Q3
$10.5M Buy
117,630
+2,050
+2% +$181K 1.04% 29
2018
Q2
$9.18M Sell
115,580
-9,691
-8% -$805K 0.97% 33
2018
Q1
$11.2M Buy
125,271
+33,791
+37% +$3.24M 1.23% 23
2017
Q4
$9.55M Buy
91,480
+21,012
+30% +$2.37M 1.01% 32
2017
Q3
$10.3M Buy
70,468
+3,150
+5% +$429K 1.15% 26
2017
Q2
$8.74M Buy
67,318
+3,015
+5% +$369K 1% 33
2017
Q1
$8M Sell
64,303
-6,798
-10% -$814K 0.92% 33
2016
Q4
$8.23M Sell
71,101
-405
-0.6% -$45.1K 0.97% 31
2016
Q3
$7.47M Sell
71,506
-14,429
-17% -$1.56M 0.88% 33
2016
Q2
$8.48M Sell
85,935
-1,846
-2% -$191K 1.02% 29
2016
Q1
$8.79M Sell
87,781
-1,450
-2% -$149K 1.07% 27
2015
Q4
$10.7M Sell
89,231
-4,265
-5% -$493K 1.28% 19
2015
Q3
$10.1M Buy
93,496
+2,940
+3% +$365K 1.24% 21
2015
Q2
$10.5M Buy
90,556
+7,994
+10% +$914K 1.15% 24
2015
Q1
$9.52M Buy
82,562
+1,680
+2% +$201K 0.99% 28
2014
Q4
$9.05M Buy
80,882
+400
+0.5% +$42.2K 0.92% 31
2014
Q3
$7.63M Sell
80,482
-850
-1% -$76.7K 0.75% 40
2014
Q2
$6.99M Sell
81,332
-1,200
-1% -$91.3K 0.7% 41
2014
Q1
$5.76M Sell
82,532
-250
-0.3% -$19.8K 0.62% 47
2013
Q4
$6.99M Sell
82,782
-7,900
-9% -$625K 0.76% 38
2013
Q3
$6.99M Buy
90,682
+20,600
+29% +$1.44M 0.81% 35
2013
Q2
$4.1M Buy
+70,082
New +$4.22M 0.5% 57

Other funds holding CELG

Neville Rodie & Shaw's CELG Position: Q4 2019 in Review

Neville Rodie & Shaw sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 93,069 shares — an estimated $9.24M sold.

Neville Rodie & Shaw first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $11.2M in Q1 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Neville Rodie & Shaw reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Neville Rodie & Shaw sold 93,069 Celgene Corp shares in Q4 2019, an estimated $9.24M.
  • Neville Rodie & Shaw first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Neville Rodie & Shaw's Celgene Corp position peaked at $11.2M in Q1 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Neville Rodie & Shaw's 13F filing for Q4 2019, filed 8 Jan 2020.